— Know what they know.
Not Investment Advice

HBRM OTC

Herborium Group, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +9900.0% 1Y: +0.0% 3Y: -33.3% 5Y: -94.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 54 · $1.1M mcap · 8.53B float · 0.0060% daily turnover · Short 20% of daily vol

Balance Sheet Trends

Total Assets
$143K -9.1% ▼
5Y CAGR: -7.1%
Total Liabilities
$4M +0.0% ▲
5Y CAGR: +42.1%
Shareholders Equity
-$4M +0.0% ▲
Cash & Investments
$5K -50.0% ▼
5Y CAGR: -17.6%
Total Debt
$1M +0.0% ▲
5Y CAGR: +21.4%
Net Debt
$1M +0.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$8K$14K$10K$10K$5K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$8K$14K$10K$10K$5K
Net Receivables$31K$13K$2K$6K$3K
Inventory$6K$22K$16K$12K$6K
Other Current Assets$0$0$0$0$0
Total Current Assets$45K$48K$28K$29K$14K
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$122K$124K$125K$128K$128K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$3K$3K$3K$0-$5
Total Non-Current Assets$125K$127K$128K$128K$128K
Total Assets$170K$175K$156K$157K$143K
— Liabilities —
Accounts Payable$234K$14K$106K$159K$70K
Short-Term Debt$402K$402K$402K$402K$402K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$414K$441K$397K$195K$728K
Total Current Liabilities$3M$3M$4M$3M$3M
Long-Term Debt$650K$650K$668K$668K$668K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$650K$650K$667K$668K$668K
Total Liabilities$4M$4M$4M$4M$4M
— Equity —
Common Stock$10M$10M$11M$11M$11M
Retained Earnings-$15M-$15M-$15M-$15M-$14M
Accumulated OCI-$69K-$10M-$11M$0$0
Total Stockholders Equity-$4M-$4M-$4M-$4M-$4M
Total Liabilities & Equity$170K$175K$156K-$186K-$186K
— Key Metrics —
Total Debt$1M$1M$1M$1M$1M
Net Debt$1M$1M$1M$1M$1M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms